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Metals make up the bulk of the periodic table and range from the very light (e.g., beryllium) to the 
very heavy (e.g., the actinides). Metals are important constituents of life, drive economic activity and 
industry, but can also be a hazard to human health. The metals can be roughly divided into three 
groups. The first being those metals, such as iron and zinc, that are essential to human life and have a 
wide therapeutic dose range. The second group of metals, such as lead, mercury, and uranium, has no 
known biological role and are toxic even at low doses. The third group of metals, such as selenium and 
manganese, has a role in maintaining human health but has a very narrow dose range that, when 
exceeded, produces toxic effects.  
A quick look at the periodic table also shows us that there is a very rough correlation between the 
atomic weights of metals and their toxicity. The heavier the metal the more likely it is to be toxic, and 
while  there  are  exceptions  (for  example,  beryllium  is  very  light  and  also  very  toxic)  this  rough 
correlation has driven our view of the relative risk of metals for many years. The approach of using 
atomic weight as a guide to toxicity seemed to work in the period of early industrialization when lead 
and mercury were being used in abundance and this concept was reinforced with the birth of nuclear 
power when heavy metals were again seen to be very toxic and, additionally, radioactive. 
In contemporary society the correlation between metal toxicity and atomic weight is no longer 
useful [1]. For one, we have come to understand that many of the lighter metals, such as aluminum, 
can be toxic. Additionally, industrial processes have moved new metals and combinations of metals 
into  the  environment.  Gallium  arsenide,  for  example,  is  used  extensively  in  the  microprocessor 
industry yet a Pub Med search yields only, at this writing, 37 articles addressing its toxicity, which in 
the world of toxicology means that it has mostly been ignored. Rechargeable batteries use a variety of 
metals to perform their function, yet despite calls for recycling, most end up in landfills with the 
potential to release nickel, mercury, cadmium, lithium and other substances into the environment [2]. 
This special edition of The International Journal of Environmental Research and Public Health has 
OPEN ACCESS Int. J. Environ. Res. Public Health 2010, 7                 
 
 
4279 
brought together authors to address a number of the issues facing those of us interested in the toxicity 
of metals. 
The fact that the nature of metal exposure is changing can be seen even in war. Uranium toxicity 
has long been an issue only for the nuclear industry but as militaries across the world accelerate the use 
of depleted uranium munitions exposure to this once exotic metal may become much more common. I 
have reviewed the toxicity of this metal and made several recommendations for continued study. 
The  medical  use  of  metal  containing  compounds  is  also  accelerating  [3].  Cisplatin  and  silver 
sulfadiazine  are  two  well  known  examples  of  metal  containing  compounds.  Many  new  metal 
containing drugs are being developed. Chitambar reviews the current state of gallium compounds as 
potential  as  an  antibiotic  and  antineoplastic  agents.  Lanthanum  is  being  used  to  control  serum 
phosphate  levels.  Tin  and  antimony  have  potential  to  treat  malignancies.  With  any  therapeutic 
compound toxicity is always an issue, either because of overdose or because of the metabolic fate of 
the drug in question. Toxicity may be more of a concern with metal containing compounds because the 
elemental core cannot be subsequently metabolized. Familiarity with the metal toxicity associated with 
new therapeutic metal compounds will be required of the physicians using these medications. Sundar 
and Chakravarty review the potential therapeutic promise, and toxicity, of antimony. 
Plum and her colleagues reminded that not only are some metals toxic, but in the case of some, for 
example zinc, deficiency continues to be an important cause of human suffering. This adds yet another 
layer to the way we must examine the role of metals in human life and medicine. 
In a vein similar to the pharmacologic application of metal based drugs work continues on ultra 
trace metals and their role and toxicity in humans. These metals (e.g., molybdenum, chromium, nickel) 
appear to play a role in human metabolism but have very narrow therapeutic windows. Balancing the 
biological  need  for  these  elements  with  the  potential  toxicities  can  be  particularly  challenging.  If 
medicinal compounds based on these metals are developed the ability to work within that narrow 
therapeutic  window  will  be  demanding  and  require  a  solid  understanding  of  the  toxicity  of  the  
metals involved.  
While we may pay more attention to new and more exotic metals many of mankind’s old nemeses 
remain. Dr. Li and colleagues remind us that mercury is still a problem. Similarly Miranda and her 
group  explore  the  continuing  effect  of  lead  on  developing  humans.  Arsenic  exposure  has  been  a 
significant issue in the developing world for many years, a topic well explored by others [4]. These 
metals may also enter the food chain as a potential route of exposure. The groups of Li and Milicevic 
explore the expanding study of the interplay of food and metals. 
Lastly, exposure to metals produces a variety of effects depending on the metal, dose, route, and 
time  frame.  Adverse  effects,  be  they  from  pollutants  or  medications,  will  need  to  be  addressed. 
Treatment for metal exposure may range from simple supportive care to the use of chelators to reduce 
metal levels rapidly. Chelation, however, is not a one size fits all strategy. The chelator selected varies 
with the metal involved, the relative risk of the metal, the risk of chelation, and the likely effectiveness 
of the chelating agent. The intricacies of chelation are discussed by Drs. Flora and Pachuari.  
In many ways those of us interested in metals find this an exciting time. Therapeutic promise is on 
the  rise  while  at  the  same  time  exposure  to  metals  as  pollutants  is  also  increasing.  The  need  to 
understand the actions, risks, and environmental status of metals will only grow with time. It is the Int. J. Environ. Res. Public Health 2010, 7                 
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hope  of  myself,  and  the  authors  within,  that  this  special  issue  of  the  International  Journal  of 
Environmental Research and Public Health will help meet the demand for that knowledge.  
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